Xvivo Perfusion AB (publ) GAAP EPS of SEK1.15, revenue of SEK241M

AI Briefing

• – Q1 earnings: GAAP EPS SEK 1.15, revenue SEK 241M, 23% organic growth and 71% gross margin.